Date: September 16-17, 2021
Online Livestream Event – Locations will vary
Dynamic Global Events (“DGE”) invites biopharma and medical device industry professionals to join them online September 16-17, 2021, for the 2nd Clinical Trial Agreements Conference. DGE’s first event was held online earlier this year and was focused greatly on the COVID-19 pandemic, the confidentiality of subject data, and the increased use of telemedicine, among other topics. The first event helped industry professionals determine what needed to be considered before entering into a clinical trial agreement.
This conference features a distinguished speaking faculty ready to offer the strategies and best practices to guide professionals through the negotiation process toward a successful clinical trial agreement result.
Featured speakers during the two-day conference on September 16-17 will include Jeff Odom, Manager, Global Clinical Trial Contracts, Trial Capabilities – Eli Lilly (NYSE: LLY); Donald Louis Joseph Campodonico, Clinical Trials Contracts Officer I – Stanford University School of Medicine; Tracie Carroll, Associate General Counsel – Turning Point Therapeutics (NASDAQ: TPTX); and many others.
Each of these speakers will be covering a specific topic area including, but not limited to, the impact of new standard contractual clauses and GDPR, the role of CROs in a clinical trial contract process; the in-depth look at negotiations between sites and sponsors; telemedicine and the role it plays with remote trial agreements; and the global landscape for clinical trial agreements.
The Scarritt Group Companies, a company that supports clinical trial solutions, is sponsoring the event. Some of the event partners for the 2nd Clinical Trial Agreements Conference include BioMed Wire, InvestorBrandNetwork, Pharma Marketing Network, MedTube, and many other industry-driven organizations.
Online registration for the event is being held by RegFox and can be completed online through DGE’s conference website. The event carried an early bird special (prior to 8/20/2021) ticket price of $996, and standard/on-demand ticket pricing is $1,196. Registration and log-in for the event will take place on September 16, between 8:30 am and 9:00 am EST. The Chairperson’s opening remarks will begin promptly at 9:00 am.
For more information, or to see a full list of keynote speakers and partners for the 2nd Clinical Trial Agreements Conference, please visit the event website.
To purchase tickets and register for the event, visit https://nnw.fm/AIBgB
About NetworkNewsWire
NetworkNewsWire (“NNW”) is a financial news and content distribution company, one of 40+ brands within the InvestorBrandNetwork (“IBN”), that provides: (1) access to a network of wire solutions via InvestorWire to reach all target markets, industries and demographics in the most effective manner possible; (2) article and editorial syndication to 5,000+ news outlets; (3) enhanced press release solutions to ensure maximum impact; (4) social media distribution via IBN millions of social media followers; and (5) a full array of corporate communications solutions. As a multifaceted organization with an extensive team of contributing journalists and writers, NNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience comprising investors, consumers, journalists and the general public. By cutting through the overload of information in today’s market, NNW brings its clients unparalleled visibility, recognition and brand awareness. NNW is where news, content and information converge.
To receive SMS text alerts from NetworkNewsWire, text “STOCKS” to 888-902-4192 (U.S. Mobile Phones Only)
For more information, please visit https://www.networknewswire.com
Please see full terms of use and disclaimers on the NetworkNewsWire website applicable to all content provided by NNW, wherever published or re-published: http://NNW.fm/Disclaimer
NetworkNewsWire (NNW)
New York, New York
www.networknewswire.com
212.418.1217 Office
[email protected]
NetworkNewsWire is part of the InvestorBrandNetwork
